Merck Company Stock Short Ratio

MRK Stock

USD 125.78 0.55 0.44%

Merck Company fundamentals help investors to digest information that contributes to Merck's financial success or failures. It also enables traders to predict the movement of Merck Stock. The fundamental analysis module provides a way to measure Merck's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Merck stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Merck Company Company Short Ratio Analysis

Merck's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Short Ratio

Short Interest

Average Trading Volume

More About Short Ratio | All Equity Analysis

Current Merck Short Ratio

1.77 X

Most of Merck's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Merck Company is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Merck Short Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for Merck is extremely important. It helps to project a fair market value of Merck Stock properly, considering its historical fundamentals such as Short Ratio. Since Merck's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Merck's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Merck's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Short Term Investments	Capital Stock	Common Stock	Long Term Debt	Good Will	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Accumulated Depreciation	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital
Total Assets		0.87	0.28	0.88	0.61	0.7	0.98	0.3	0.8	0.49	0.16	0.95	0.95	0.73	0.65	-0.27	0.44	-0.21	-0.22	0.19	0.35	0.22	0.36	0.31	-0.7	0.02	0.19	0.2	0.15
Total Stockholder Equity	0.87		-0.07	0.59	0.43	0.4	0.9	0.08	0.93	0.05	0.37	0.72	0.72	0.36	0.22	0.18	0.21	-0.26	0.23	-0.07	-0.02	0.1	0.61	0.48	-0.48	-0.37	-0.07	0.16	0.35
Net Debt	0.28	-0.07		0.57	0.75	0.83	0.18	0.11	-0.09	0.73	-0.2	0.42	0.42	0.74	0.71	-0.89	0.5	0.52	-0.58	0.54	0.82	0.58	-0.42	-0.26	-0.43	0.32	0.56	0.48	-0.1
Retained Earnings	0.88	0.59	0.57		0.69	0.83	0.84	0.26	0.5	0.8	0.01	0.9	0.9	0.91	0.89	-0.65	0.58	0.03	-0.48	0.37	0.65	0.37	0.04	0.04	-0.74	0.24	0.48	0.37	0.18
Net Receivables	0.61	0.43	0.75	0.69		0.91	0.57	0.13	0.47	0.6	-0.28	0.63	0.63	0.68	0.57	-0.63	0.71	0.5	-0.35	0.51	0.6	0.68	0.08	-0.26	-0.59	0.01	0.58	0.6	0.16
Total Liab	0.7	0.4	0.83	0.83	0.91		0.64	0.35	0.4	0.75	-0.17	0.78	0.78	0.81	0.78	-0.77	0.56	0.25	-0.59	0.52	0.65	0.45	-0.05	-0.09	-0.75	0.28	0.46	0.38	-0.03
Total Current Assets	0.98	0.9	0.18	0.84	0.57	0.64		0.31	0.82	0.4	0.21	0.91	0.91	0.64	0.55	-0.18	0.4	-0.25	-0.12	0.15	0.24	0.18	0.38	0.33	-0.71	-0.06	0.18	0.16	0.19
Short Term Debt	0.3	0.08	0.11	0.26	0.13	0.35	0.31		0.12	0.3	-0.27	0.41	0.41	0.13	0.26	-0.22	0.03	-0.44	-0.47	0.19	-0.13	-0.35	-0.04	0.1	-0.63	0.73	-0.13	-0.43	-0.63
Intangible Assets	0.8	0.93	-0.09	0.5	0.47	0.4	0.82	0.12		0.07	0.15	0.65	0.65	0.29	0.16	0.19	0.28	-0.21	0.14	-0.05	-0.05	0.11	0.75	0.25	-0.47	-0.31	-0.09	0.14	0.22
Accounts Payable	0.49	0.05	0.73	0.8	0.6	0.75	0.4	0.3	0.07		-0.37	0.58	0.58	0.85	0.9	-0.9	0.63	0.25	-0.75	0.44	0.8	0.38	-0.33	-0.39	-0.65	0.57	0.58	0.39	-0.09
Short Term Investments	0.16	0.37	-0.2	0.01	-0.28	-0.17	0.21	-0.27	0.15	-0.37		0.14	0.14	-0.11	-0.14	0.39	-0.55	-0.48	0.36	-0.28	-0.27	-0.35	0.22	0.77	0.11	-0.4	-0.48	-0.3	0.08
Capital Stock	0.95	0.72	0.42	0.9	0.63	0.78	0.91	0.41	0.65	0.58	0.14		1.0	0.77	0.76	-0.42	0.38	-0.27	-0.43	0.3	0.38	0.19	0.24	0.29	-0.7	0.21	0.23	0.06	-0.03
Common Stock	0.95	0.72	0.42	0.9	0.63	0.78	0.91	0.41	0.65	0.58	0.14	1.0		0.77	0.76	-0.42	0.38	-0.27	-0.43	0.3	0.38	0.19	0.24	0.29	-0.7	0.21	0.23	0.06	-0.03
Long Term Debt	0.73	0.36	0.74	0.91	0.68	0.81	0.64	0.13	0.29	0.85	-0.11	0.77	0.77		0.93	-0.76	0.67	0.23	-0.52	0.41	0.88	0.56	-0.2	-0.09	-0.58	0.24	0.6	0.49	0.11
Good Will	0.65	0.22	0.71	0.89	0.57	0.78	0.55	0.26	0.16	0.9	-0.14	0.76	0.76	0.93		-0.83	0.51	0.07	-0.75	0.5	0.79	0.33	-0.2	-0.1	-0.56	0.49	0.51	0.28	-0.02
Treasury Stock	-0.27	0.18	-0.89	-0.65	-0.63	-0.77	-0.18	-0.22	0.19	-0.9	0.39	-0.42	-0.42	-0.76	-0.83		-0.55	-0.44	0.77	-0.56	-0.83	-0.46	0.51	0.43	0.51	-0.54	-0.67	-0.4	0.07
Property Plant Equipment	0.44	0.21	0.5	0.58	0.71	0.56	0.4	0.03	0.28	0.63	-0.55	0.38	0.38	0.67	0.51	-0.55		0.61	-0.23	0.39	0.71	0.84	-0.05	-0.6	-0.41	0.04	0.85	0.75	0.24
Current Deferred Revenue	-0.21	-0.26	0.52	0.03	0.5	0.25	-0.25	-0.44	-0.21	0.25	-0.48	-0.27	-0.27	0.23	0.07	-0.44	0.61		0.07	0.28	0.58	0.81	-0.33	-0.65	0.07	-0.25	0.66	0.85	0.43
Net Tangible Assets	-0.22	0.23	-0.58	-0.48	-0.35	-0.59	-0.12	-0.47	0.14	-0.75	0.36	-0.43	-0.43	-0.52	-0.75	0.77	-0.23	0.07		-0.51	-0.46	0.02	0.23	0.33	0.4	-0.82	-0.31	0.14	0.45
Total Permanent Equity	0.19	-0.07	0.54	0.37	0.51	0.52	0.15	0.19	-0.05	0.44	-0.28	0.3	0.3	0.41	0.5	-0.56	0.39	0.28	-0.51		0.43	0.31	0.0	-0.35	-0.3	0.25	0.41	0.25	-0.04
Long Term Debt Total	0.35	-0.02	0.82	0.65	0.6	0.65	0.24	-0.13	-0.05	0.8	-0.27	0.38	0.38	0.88	0.79	-0.83	0.71	0.58	-0.46	0.43		0.72	-0.42	-0.38	-0.31	0.18	0.74	0.69	0.18
Capital Surpluse	0.22	0.1	0.58	0.37	0.68	0.45	0.18	-0.35	0.11	0.38	-0.35	0.19	0.19	0.56	0.33	-0.46	0.84	0.81	0.02	0.31	0.72		-0.14	-0.47	-0.08	-0.29	0.82	0.84	0.39
Deferred Long Term Liab	0.36	0.61	-0.42	0.04	0.08	-0.05	0.38	-0.04	0.75	-0.33	0.22	0.24	0.24	-0.2	-0.2	0.51	-0.05	-0.33	0.23	0.0	-0.42	-0.14		0.15	0.01	-0.33	-0.33	-0.14	0.08
Long Term Investments	0.31	0.48	-0.26	0.04	-0.26	-0.09	0.33	0.1	0.25	-0.39	0.77	0.29	0.29	-0.09	-0.1	0.43	-0.6	-0.65	0.33	-0.35	-0.38	-0.47	0.15		-0.03	-0.22	-0.6	-0.43	0.01
Accumulated Depreciation	-0.7	-0.48	-0.43	-0.74	-0.59	-0.75	-0.71	-0.63	-0.47	-0.65	0.11	-0.7	-0.7	-0.58	-0.56	0.51	-0.41	0.07	0.4	-0.3	-0.31	-0.08	0.01	-0.03		-0.35	-0.17	-0.15	0.12
Short Long Term Debt	0.02	-0.37	0.32	0.24	0.01	0.28	-0.06	0.73	-0.31	0.57	-0.4	0.21	0.21	0.24	0.49	-0.54	0.04	-0.25	-0.82	0.25	0.18	-0.29	-0.33	-0.22	-0.35		0.07	-0.34	-0.65
Cash And Equivalents	0.19	-0.07	0.56	0.48	0.58	0.46	0.18	-0.13	-0.09	0.58	-0.48	0.23	0.23	0.6	0.51	-0.67	0.85	0.66	-0.31	0.41	0.74	0.82	-0.33	-0.6	-0.17	0.07		0.67	0.34
Net Invested Capital	0.2	0.16	0.48	0.37	0.6	0.38	0.16	-0.43	0.14	0.39	-0.3	0.06	0.06	0.49	0.28	-0.4	0.75	0.85	0.14	0.25	0.69	0.84	-0.14	-0.43	-0.15	-0.34	0.67		0.64
Net Working Capital	0.15	0.35	-0.1	0.18	0.16	-0.03	0.19	-0.63	0.22	-0.09	0.08	-0.03	-0.03	0.11	-0.02	0.07	0.24	0.43	0.45	-0.04	0.18	0.39	0.08	0.01	0.12	-0.65	0.34	0.64

Click cells to compare fundamentals

The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.

Competition

Predict Merck

Based on the latest financial disclosure, Merck Company has a Short Ratio of 1.77 times. This is 54.62% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The short ratio for all United States stocks is 55.75% higher than that of the company.

Merck Short Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Merck's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Merck could also be used in its relative valuation, which is a method of valuing Merck by comparing valuation metrics of similar companies.

Merck is currently under evaluation in short ratio category among related companies.

Merck ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Merck's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Merck's managers, analysts, and investors.

Environment Score

Governance Score

Social Score

Merck Institutional Holders

Institutional Holdings refers to the ownership stake in Merck that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Merck's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Merck's value.

		Shares
Northern Trust Corp	2023-12-31	28.5 M
Jpmorgan Chase & Co	2023-12-31	25.4 M
Goldman Sachs Group Inc	2023-12-31	24.2 M
Legal & General Group Plc	2023-12-31	23.5 M
Deutsche Bank Ag	2023-12-31	21.6 M
Bank Of New York Mellon Corp	2023-12-31	20.8 M
Amvescap Plc.	2023-12-31	16.8 M
Nuveen Asset Management, Llc	2023-12-31	16.7 M
Ameriprise Financial Inc	2023-12-31	16.4 M
Vanguard Group Inc	2023-12-31	244.8 M
Blackrock Inc	2023-12-31	201.8 M

Merck Fundamentals

	Return On Equity	0.009
	Return On Asset	0.0264
	Profit Margin	0.01 %
	Operating Margin	0.0008 %
	Current Valuation	345.96 B
	Shares Outstanding	2.53 B
	Shares Owned By Insiders	0.04 %
	Shares Owned By Institutions	78.56 %
	Number Of Shares Shorted	19.59 M
	Price To Earning	18.05 X
	Price To Book	8.48 X
	Price To Sales	5.30 X
	Revenue	59.87 B
	Gross Profit	42.08 B
	EBITDA	6.85 B
	Net Income	365 M
	Cash And Equivalents	12.69 B
	Cash Per Share	4.44 X
	Total Debt	36.27 B
	Debt To Equity	0.68 %
	Current Ratio	1.46 X
	Book Value Per Share	14.85 X
	Cash Flow From Operations	13.01 B
	Short Ratio	1.77 X
	Earnings Per Share	0.14 X
	Price To Earnings To Growth	0.10 X
	Target Price	137.02
	Number Of Employees	70 K
	Beta	0.4
	Market Capitalization	316.78 B
	Total Asset	106.67 B
	Retained Earnings	53.9 B
	Working Capital	6.47 B
	Current Asset	29.76 B
	Current Liabilities	19.2 B
	Annual Yield	0.02 %
	Five Year Return	2.99 %
	Net Asset	106.67 B
	Last Dividend Paid	2.92

About Merck Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Merck Company's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merck using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merck Company based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Merck Investors Sentiment

The influence of Merck's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Merck. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Merck's public news can be used to forecast risks associated with an investment in Merck. The trend in average sentiment can be used to explain how an investor holding Merck can time the market purely based on public headlines and social activities around Merck Company. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Merck's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Merck's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Merck's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Merck.

Merck Implied Volatility

38.6

Merck's implied volatility exposes the market's sentiment of Merck Company stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Merck's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Merck stock will not fluctuate a lot when Merck's options are near their expiration.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Merck in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Merck's short interest history, or implied volatility extrapolated from Merck options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:

How To Invest In Merck

Details

Is Merck Stock a good investment?

Details

What is Merck's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Merck Piotroski F Score and Merck Altman Z Score analysis.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.

	Global Correlations Find global opportunities by holding instruments from different markets
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories

Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.453

Dividend Share

2.92

Earnings Share

0.14

Revenue Per Share

23.695

Quarterly Revenue Growth

0.058

The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Merck Company Stock Short Ratio

Merck Company Company Short Ratio Analysis

Short Ratio

Short Interest

Average Trading Volume

Current Merck Short Ratio

Merck Short Ratio Driver Correlations

Merck Short Ratio Peer Comparison

Merck ESG Sustainability

Merck Institutional Holders

Merck Fundamentals

About Merck Fundamental Analysis

Merck Investors Sentiment

Merck Implied Volatility

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Merck Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY